New sleep program aims to help veterans transition home
NCT ID NCT07317336
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a 4-week telehealth program called I-SLEPT for Veterans leaving a rehabilitation facility. The program combines sleep education and tips for staying active in meaningful activities. Researchers want to see if it is acceptable and feasible for Veterans, and whether it improves sleep and life engagement during the transition home.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- I-SLEPT behavioral intervention (telehealth sessions with a psychologist)
- What this could lead to
- If it works, this could offer a practical, home-based program to help Veterans sleep better and stay active after rehab.
- What could go wrong
- This is a small, early-stage study (60 people) testing feasibility, not effectiveness. Results may not apply to all Veterans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARTICIPATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
RECRUITINGBoston, Massachusetts, 02130-4817, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A 45-Minute lesson could sharpen Students' minds and sleep
- Can a sleepless night rewire hunger and memory?
- Melatonin bath products: are they absorbed like pills?
- Can a strange bed sabotage your workout? sex differences put to the test
- Can your pupils reveal the secrets of sleep and body clocks?
- Can fish oil calm ADHD and autism symptoms? a new trial investigates